Samuel M Moskowitz MD (He/Him)

Physician

28 Manitoba RdNewton, MA 02468

Dr. Moskowitz is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moskowitz's full profile Already have an account?

Education & Training

University of WashingtonFellowship, Pediatric Pulmonology, 1997 - 2001
University of WashingtonResidency, Pediatrics, 1994 - 1997
Harvard Medical SchoolClass of 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2008 - 2027
NH State Medical License 2023 - 2027
AK State Medical License 2006 - 2010
American Board of Pediatrics Pediatric Pulmonology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2015

Clinical Trials

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)
COMPLETED
NA

Publications & Presentations

PubMed

55 citations
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least oneallele: 144-week interim results from a 192-week open-...
Cori L Daines, Elizabeth Tullis, Stefano Costa, Rachel W Linnemann, Marcus A Mall
The European Respiratory Journal. 2023-12-01
34 citations
Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor.
Isabelle Fajac, Cori Daines, Isabelle Durieu, Jennifer L Goralski, Harry Heijerman
Journal of Cystic Fibrosis. 2023-01-01
88 citations
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous forand a Minimal Function Mutation: A P...
Marcus A Mall, Rossa Brugha, Silvia Gartner, Julian Legg, Alexander Moeller
American Journal of Respiratory and Critical Care Medicine. 2022-12-01

Press Mentions

Characterization of Pseudomonas Aeruginosa from Subjects with Diffuse PanbronchiolitisOctober 8th, 2024

Grant Support

Polymyxin-Resistant Pseudomonas In CF Lung InfectionNational Institute Of Allergy And Infectious Diseases2009–2010
Polymyxin-Resistant Pseudomonas In CF Lung InfectionNational Institute Of Allergy And Infectious Diseases2007–2008
Standard Versus Biofilm Susceptibility Testing In Cystic Fibrosis (CF)National Center For Research Resources2006
Influence Of ENAC Regulators On CF Lung SeverityNational Heart, Lung, And Blood Institute2005–2006
Genetics Of Cystic Fibrosis Lung SparingNational Center For Research Resources2004–2005